Drupanin
Based on 1 Customer Validation
Drupanin is an orally active and selective AKR1C3 enzyme inhibitor and an RXRα agonist with an EC50 value of 4.8 μM, which is found in green propolis. Drupanin also activates PPARγ moderately. Drupanin induces adipogenesis and elevates aP2 mRNA levels in 3T3-L1 fibroblasts Drupanin has the potential for the research of breast and prostate cancers.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.35%
- CAS No.: 53755-58-1
- 화학식: C14H16O3
- 분자량:232.28
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
PPARα 39.0 μM (EC50) |
AKR1C3 |
PPARγ 14.6 μM (EC50) |
PPARδ N.D.(not d () |
RXR α 2.1 μM (EC50) |
RXRγ 4.6 μM (EC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
>200 μM
Compound: 2
|
Antiproliferative activity against human DU-145 cells assessed as cell viability for 72 hrs by MTT assay
Antiproliferative activity against human DU-145 cells assessed as cell viability for 72 hrs by MTT assay
|
[PMID: 34454129] |
| HEK293 | IC50 |
25.6 μM
Compound: 9
|
Modulation of HIF1 expressed in HEK293 cells assessed as luciferase activity under hypoxic condition after 24 hrs by luminometer analysis
Modulation of HIF1 expressed in HEK293 cells assessed as luciferase activity under hypoxic condition after 24 hrs by luminometer analysis
|
[PMID: 21865046] |
| HeLa | IC50 |
10.3 μg/mL
Compound: 3
|
Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA
Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA
|
[PMID: 19942440] |
| MCF-10A | CC50 |
>200 μM
Compound: 2
|
Cytotoxicity against human MCF-10A cells assessed as cell viability for 72 hrs by MTT assay
Cytotoxicity against human MCF-10A cells assessed as cell viability for 72 hrs by MTT assay
|
[PMID: 34454129] |
| MCF7 | IC50 |
>200 μM
Compound: 2
|
Antiproliferative activity against human MCF7 cells assessed as cell viability for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell viability for 72 hrs by MTT assay
|
[PMID: 34454129] |
| MDA-MB-231 | IC50 |
>200 μM
Compound: 2
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability for 72 hrs by MTT assay
|
[PMID: 34454129] |
| PC-3 | IC50 |
>200 μM
Compound: 2
|
Antiproliferative activity against human PC-3 cells assessed as cell viability for 72 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as cell viability for 72 hrs by MTT assay
|
[PMID: 34454129] |
| PNT2 | CC50 |
>200 μM
Compound: 2
|
Cytotoxicity against human PNT2 cells assessed as cell viability for 72 hrs by MTT assay
Cytotoxicity against human PNT2 cells assessed as cell viability for 72 hrs by MTT assay
|
[PMID: 34454129] |
Drupanin (2.5-25 μM, 1 h) stimulates the interaction between PPARγ and cAMP responsive element-binding protein-binding protein in HEK 293 cells (EC50 value: 14.6 μM)[2].
Drupanin (25 μM, 5 days) enhances the adipogenesis of mouse 3T3-L1 fibroblasts[2].
Drupanin (101.7-103.5 μM, 48 h) shows cytotoxic effects on PC3 and LnCaP cells[3].
The EC50 values of Drupanin for each RXR subtype cofactor[2]
| subtypes | RXRα | RXRγ | RXRδ |
| EC50 (μM) | 2.1 | 4.6 | 7.0 |